These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]. Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA. Tsitol Genet; 1998 Jan; 32(1):66-71. PubMed ID: 9695254 [Abstract] [Full Text] [Related]
27. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening. Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR. Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861 [Abstract] [Full Text] [Related]
28. [Triple test: problem or enhancement of prenatal diagnosis]. Rauskolb R, Engel W. Z Geburtshilfe Neonatol; 1995 Aug; 199(3):91. PubMed ID: 7553260 [No Abstract] [Full Text] [Related]
29. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18. Summers AM, Huang T, Wyatt PR. Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909 [No Abstract] [Full Text] [Related]
30. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ, Watt HC. Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [Abstract] [Full Text] [Related]
31. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315 [Abstract] [Full Text] [Related]
32. Contemporary approaches to prenatal diagnosis. Kuller JA, Laifer SA. Am Fam Physician; 1995 Dec; 52(8):2277-83, 2285-6. PubMed ID: 7484721 [Abstract] [Full Text] [Related]
33. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test]. van den Boer-van den Berg JM, Dupuis HM. Ned Tijdschr Geneeskd; 1993 Jun 26; 137(26):1286-9. PubMed ID: 7688445 [No Abstract] [Full Text] [Related]
34. Maternal serum triple analyte screening in pregnancy. Graves JC, Miller KE, Sellers AD. Am Fam Physician; 2002 Mar 01; 65(5):915-20. PubMed ID: 11898965 [Abstract] [Full Text] [Related]
35. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA, Ying J, Beazoglou T, Egan JF. Prenat Diagn; 2001 Jan 01; 21(1):46-51. PubMed ID: 11180240 [Abstract] [Full Text] [Related]
36. [Prenatal screening for major fetal defects by using of maternal serum markers]. Bao P, Wu Y, Gu Q. Zhonghua Fu Chan Ke Za Zhi; 1997 Nov 01; 32(11):649-51. PubMed ID: 9639762 [Abstract] [Full Text] [Related]
37. Triple marker screening in native Japanese women. Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, Bradley LA, Canick JA, Krasikov NE, Ponting NR, Grier RE. Prenat Diagn; 1996 Aug 01; 16(8):713-7. PubMed ID: 8878280 [Abstract] [Full Text] [Related]
38. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach]. Senat MV, Rozenberg P, Bernard JP, Ville Y. J Gynecol Obstet Biol Reprod (Paris); 2001 Feb 01; 30(1):11-27. PubMed ID: 11240502 [No Abstract] [Full Text] [Related]
39. Maternal serum screening for neural tube defects and Down's syndrome. Robertson EF. Med J Aust; 1991 Jul 15; 155(2):67-8. PubMed ID: 1713290 [No Abstract] [Full Text] [Related]
40. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Prenat Diagn; 1996 Dec 15; 16(12):1115-9. PubMed ID: 8994247 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]